The risk of type 2 diabetes is reduced by more than half by weekly injections of the new obesity drug Wegovy (semaglutide). This is according to new research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Stockholm, Sweden (September 19-23).
Semaglutide was recently approved in the US by the Food and Drug Administration as an obesity treatmentand has been provisionally approved by The National Institute for Health and Care Excellence to treat obesity in England.“Semaglutide appears to be the most effective medication to date for treating obesity and is beginning to close the gap with the amount of weight loss following bariatric surgery,” says Dr. W. Timothy Garvey, who led the research.
“This amount of weight loss is sufficient to treat or prevent a broad array of obesity complications that impair health and quality of life and is a game changer in obesity medicine.” CDMS has been previously shown to be a highly accurate measure of type 2 diabetes risk and is calculated using a formula that factors in a patient’s sex, age, race, BMI, and blood pressure, as well as blood glucose, HDL cholesterol, and triglyceride levels.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Increased Risk of Depression Among Young People With T2 DiabetesPeople who develop type 2 diabetes (T2D) before age 40 have an increased – and increasing – risk of co-morbid depression, according to a new study
Weiterlesen »
Tiny 'Drug Factory' Implants Can Eradicate Tumors in Mice in Just DaysScientists have managed to stop advanced-stage cancers in mice through the use of implanted 'drug factories' – and the new type of treatment only takes a few days to become effective.
Weiterlesen »
Walking this number of steps every day can reduce dementia risk by 50%A new study points to how much and how quickly you should walk to reduce your risk of dementia.
Weiterlesen »
Reduce Your Risk of Death by Up to 31%: New Study Examines the Impact of ExerciseA study finds that adults who exercised 150-600 minutes each week had the lowest risk of death. According to a recent study published in the American Heart Association's flagship peer-reviewed journal Circulation, individuals who exercise two to four times the currently recommended level of moderat
Weiterlesen »